Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025
Posted On Monday, February 24, 2025
BridgeBio Initiates Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes to Refinance Senior Secured Debt
Posted On Monday, February 24, 2025
Revolution Medicines to Participate in March 2025 Investor Conferences
Posted On Monday, February 24, 2025
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth
Posted On Monday, February 24, 2025
Cardiff Oncology to Present at Upcoming Investor Conferences
Posted On Monday, February 24, 2025
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
Posted On Monday, February 24, 2025
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
Posted On Monday, February 24, 2025
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Posted On Monday, February 24, 2025
XOMA Royalty to Present at Investor Conferences in March
Posted On Monday, February 24, 2025
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
Posted On Monday, February 24, 2025
Myriad Genetics Announces Senior Leadership Transition
Posted On Monday, February 24, 2025
Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025
Posted On Monday, February 24, 2025
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Monday, February 24, 2025
Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial
Posted On Monday, February 24, 2025
AEON Biopharma, Inc. Announces Reverse Stock Split
Posted On Monday, February 24, 2025
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
Posted On Monday, February 24, 2025
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
Posted On Monday, February 24, 2025
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
Posted On Monday, February 24, 2025
Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
Posted On Monday, February 24, 2025
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
Posted On Monday, February 24, 2025
Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March
Posted On Monday, February 24, 2025
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
Posted On Monday, February 24, 2025
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
Posted On Monday, February 24, 2025
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
Posted On Monday, February 24, 2025
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
Posted On Monday, February 24, 2025

Print